Non-Alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth to 2028 | Key Players ...

Retrieved on: 2021-07-04 23:15:00

Tags for this article:

Click the tags to see associated articles and topics

Non-Alcoholic Fatty Liver Disease (NAFLD) Drug Market Size and Growth to 2028 | Key Players .... View article details on hiswai:

Excerpt

F. Hoffmann-La Roche Ltd, Pfizer, Merck & Co., AstraZeneca plc, Gilead, GW Pharmaceuticals plc. Photo of Joseph Watson Joseph WatsonJuly 4, 2021.

Article found on: manometcurrent.com